Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 170 (1) , 168-176
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: Results from an aborted randomised trialInternational Journal of Psychiatry in Clinical Practice, 2010
- Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trialBMJ, 2010
- The Cost of Relapse in Schizophrenia and Schizoaffective DisorderAustralasian Psychiatry, 2009
- Maintenance Treatment With Risperidone or Low-Dose Haloperidol in First-Episode SchizophreniaThe Journal of Clinical Psychiatry, 2007
- Revisiting the relapse predictive validity of prodromal symptoms in schizophreniaSchizophrenia Research, 2007
- Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode PsychosisThe Journal of Clinical Psychiatry, 2007
- Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapseActa Psychiatrica Scandinavica, 2006
- A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychological Medicine, 1983
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960